Navigation Links
The Acta Materialia Inc Announces New Chairman of the Board of Governors
Date:9/6/2012

NEW YORK, September 6, 2012 /PRNewswire/ --

Dr George "Rusty" Gray II to further nurture Acta's three leading journals in the material sciences: Acta Materialia, Scripta Materialia, and Acta Biomaterialia

Acta Materialia Inc. is pleased to announce that Dr George "Rusty" Gray II has been appointed as Chairman of the Board of Governors of Acta Materialia Inc. effective immediately. He succeeds Dr William F. Scott who passed away June 25, 2012.

Rusty, a native of New York, earned his PhD from Carnegie-Mellon University in 1981 and is currently a Laboratory Fellow and staff member in the dynamic properties and constitutive modeling team within the Materials Science Division of Los Alamos National Laboratory. He has served as the TMS representative on the Acta Board of Governors since 2004.

Dr Gray said of his appointment, "I am honored and excited to serve as the Chair of the Board of Governors of Acta Materialia, Inc. and look forward to nurturing and growing the strengths represented by Acta's three journals to keep them at the forefront of the rapidly evolving research topics in materials science and engineering research."

Founded in 1953, the Acta Materialia Inc., in collaboration with Elsevier, publish three high quality journals, Acta Materialia, Scripta Materialia, and Acta Biomaterialia, which cover the areas of materials science, biomaterials, materials engineering, and materials chemistry and physics. Acta Materialia is the leading journal in its field with an impact factor of 3.755. Acta Materialia Inc. supports and promotes scientific meetings, award prizes, and undertakes other activities to further its fundamental purpose and promote the science and engineering of materials science.

"Rusty is still very active in research, is familiar with contemporary issues in materials research, and the three journals will benefit substantially from his demonstrated leadership," stated Subhash Mahajan,Coordinating Editor of the journals at  Acta Materialia Inc.

About Elsevier

Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include ScienceDirect, Scopus, Reaxys, ClinicalKey and Mosby's Nursing Suite, which enhance the productivity of science and health professionals, and the SciVal suite and MEDai's Pinpoint Review, which help research and health care institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC, a world-leading publisher and information provider, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

Media contact
Allyn Molina
+1-212-633-3656
a.molina@elsevier.com


'/>"/>
SOURCE Elsevier
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. PDL BioPharma Announces Conversion Rate Adjustments for Convertible Notes
2. RayBiotech, Inc. Achieves Both GMP- and GLP-Compliance and Announces New Dedicated Services Laboratory
3. Tufts Medical Center Announces Inaugural INNOVATION Day: Innovating a Path to Market
4. ESTEVE Announces the Publication of Comprehensive Phase I Data for a Novel Oral, First-in-class New Chemical Entity (NCE),E-52862, a Sigma-1 Receptor Antagonist (S1RA) Being Developed for Pain
5. Texas Medical Center, the largest concentration of medical research, educational and healthcare organizations in the world, announces the first Houston Stem Cell Summit to highlight the latest stem cell research and commercialization efforts
6. Sangamo BioSciences Announces Presentation At The Stifel Nicolaus 2012 Healthcare Conference
7. ARMGO Pharma, Inc. announces data which supports its Rycal program as a novel approach for the treatment of stress-induced cognitive disorders
8. Bolder BioTechnology Announces Publication of Data Demonstrating Utility of the Companys Long-Acting IL-11 Analog to Prevent Renal Ischemia Reperfusion Injury
9. Clinical Site Services, Industry Leader in Patient Enrollment Solutions, Announces New Website
10. Debiopharm Announces First Patient Enrolled in Phase III Study for the Rare Disease Central Precocious Puberty
11. Pinnaclife, Inc., Announces NDC, Inc., to Exclusively Distribute the New Animal Health Product Line!
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... , June 27, 2016  Liquid Biotech ... announced the funding of a Sponsored Research Agreement ... circulating tumor cells (CTCs) from cancer patients.  The ... in CTC levels correlate with clinical outcomes in ... These data will then be employed to support ...
(Date:6/24/2016)... ... ... While the majority of commercial spectrophotometers and fluorometers use the z-dimension of 8.5 ... end machines that use the more unconventional z-dimension of 20mm. Z-dimension or ... the cuvette holder. , FireflySci has developed several Agilent flow cell product lines ...
(Date:6/23/2016)... , June 23, 2016   Boston ... of novel compounds designed to target cancer stemness ... has been granted Orphan Drug Designation from the ... treatment of gastric cancer, including gastroesophageal junction (GEJ) ... inhibitor designed to inhibit cancer stemness pathways by ...
(Date:6/23/2016)... ... June 23, 2016 , ... Charm Sciences, Inc. is ... has received AOAC Research Institute approval 061601. , “This is another AOAC-RI approval ... Bob Salter, Vice President of Regulatory and Industrial Affairs. “The Peel Plate methods ...
Breaking Biology Technology:
(Date:4/13/2016)... physicians supporting Medicaid patients in Central Florida ... telehealth thanks to a new partnership with higi.   ... can routinely track key health measurements, such as blood ... they opt in, share them with IMPOWER clinicians through ... location at no cost. By leveraging this data, IMPOWER ...
(Date:3/31/2016)... , March 31, 2016  Genomics firm Nabsys has ... CEO, Barrett Bready , M.D., who returned to ... the original technical leadership team, including Chief Technology Officer, ... Product Development, Steve Nurnberg and Vice President of Software ... the company. Dr. Bready served as CEO ...
(Date:3/23/2016)... Massachusetts , March 23, 2016 /PRNewswire/ ... im Interesse erhöhter Sicherheit Gesichts- und Stimmerkennung ... Xura, Inc. (NASDAQ: MESG ), ... bekannt, dass das Unternehmen mit SpeechPro zusammenarbeitet, ... aus der Finanzdienstleistungsbranche, wird die Möglichkeit angeboten, ...
Breaking Biology News(10 mins):